1. 104. The long-term outcomes of combined therapy of adult patients with localized synovial sarcoma. Issue 9 (September 2016) Authors: Kozak, K.; Koseła-Paterczyk, H.; Switaj, T.; Klimczak, A.; Ługowska, I.; Falkowski, S.; Tadeusz, M.; Szacht, M.; Rutkowski, P. Journal: European journal of surgical oncology Issue: Volume 42:Issue 9(2016:Sep.) Page Start: S109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 107. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate. Issue 9 (September 2016) Authors: Rutkowski, P.; Klimczak, A.; Switaj, T.; Jagielska, B.; Lugowska, I.; Wagrodzki, M.; Debiec-Rychter, M.; Woroniecka, R.; Pienkowska-Grela, B. Journal: European journal of surgical oncology Issue: Volume 42:Issue 9(2016:Sep.) Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 108. The analysis of outcomes of primary cutaneous melanoma located on hand or foot undergoing sentinel lymph node biopsy. Issue 9 (September 2016) Authors: Rutkowski, P.; Spalek, M.; Stepniak, J.; Dziewirski, W.; Kozak, K.; Koseła-Paterczyk, H.; Szumera-Cieckiewicz, A.; Pieńkowski, A.; Kowalik, A.; Goryn, T.; Zdzienicki, M. Journal: European journal of surgical oncology Issue: Volume 42:Issue 9(2016:Sep.) Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 115P Reflectance confocal microscopy: An in vivo method of visualization of NMSC under anti-PD-1 therapy in correlation to histological findings - Preliminary report. (December 2022) Authors: Slowinska, M.A.; Szumera-Cieckiewicz, A.; Czarnecka, I.; Chelstowska, M.; Dawidowska, A.; Jaczewska, S.; Rutkowski, P.; Lugowska, I. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2BA The interval between primary melanoma excision and sentinel node biopsy (SNB) does not affect survival; regardless of SNB status - an EORTC Melanoma Group study. (September 2015) Authors: Oude Ophuis, C.; Verhoef, C.; Rutkowski, P.; Voit, C.; Cook, M.; Van Leeuwen, P.; Testori, A.; Hoekstra, H.; Grünhagen, D.; Eggermont, A.; Van Akkooi, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 3301 Two year estimate of overall survival in COMBI-v, a randomized, open-label, phase III study comparing the combination of dabrafenib (D) and trametinib (T) with vemurafenib (Vem) as first-line therapy in patients (pts) with unresectable or metastatic BRAF V600E/K mutation-positive cutaneous melanoma. (September 2015) Authors: Robert, C.; Karaszewska, B.; Schachter, J.; Rutkowski, P.; Mackiewicz, A.; Stroyakovskiy, D.; Lichinitser, M.; Dummer, R.; Grange, F.; Mortier, L.; Chiarion-Sileni, V.; Drucis, K.; Krajsova, I.; Hauschild, A.; Mookerjee, B.; Legos, J.; Schadendorf, D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 3313 The next generation sequencing (NGS) analysis of selected genes and pathways in clinical stage III cutaneous melanoma. (September 2015) Authors: Lugowska, I.; Mierzejewska, E.; Kowalik, A.; Gos, A.; Zięba, S.; Siedlecki, J.; Kosea-Paterczyk, H.; Szumera-Ciéckiewicz, A.; Jurkowska, M.; Rutkowski, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 3345 COMBI-v: health-related quality of life (HRQoL) impact of the combination of dabrafenib and trametinib (D+T) vs vemurafenib (V) in patients with BRAF V600 metastatic melanoma (MM). (September 2015) Authors: Grob, J.J.; Amonkar, M.; Karaszewska, B.; Schachter, J.; Dummer, R.; Mackiewicz, A.; Stroiakovski, D.; Drucis, K.; Grange, F.; Chiarion-Sileni, V.; Rutkowski, P.; Lichinitser, M.; Levchenko, E.; Wolter, P.; Hauschild, A.; Long, G.V.; Sun, P.; McDowell, D.O.; Mookerjee, B.; Robert, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 3348 Cell-free DNA V600E measurements during vemurafenib therapy of metastatic melanoma patients. (September 2015) Authors: Kozak, K.; Lugowska, I.; Kowalik, A.; Gos, A.; Jurkowska, M.; Stępniak, J.; Switaj, T.; Paterczyk, H. Kosela; Klimczak, A.; Falkowski, S.; Jagielska, B.; Siedlecki, J.; Chlopek, M.; Kalisz, J.; Rutkowski, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 3404 External validation of a nomogram predicting disease-free (DFS) and overall survival (OS) in patients (pts) with primary retroperitoneal sarcoma (pRPS). (September 2015) Authors: Raut, C.; Miceli, R.; Strauss, D.; Swallow, C.; Hohenberger, P.; Coevorden, F. Van; Rutkowski, P.; Fiore, M.; Callegaro, D.; Casali, P.; Haas, R.; Hayes, A.; Honore, C.; Cannell, A.; Jakob, J.; Szacht, M.; Fairweather, M.; Pollock, R.; Bonvalot, S.; Gronchi, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗